The relative importance of phytosterol in BPH therapy;Der Stellenwert von phytosterol in der BPH-therapie

Zeitschrift fur Phytotherapie

Volumn 24, Issue 5, 2003, Pages 222-224

  Bauer, Hartwig W ^a  

^a Facharzt für Urologie ^*  (Germany)

Author keywords

BPH therapy; Efficacy; Micturition complaints; Phytosterol

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; FINASTERIDE; PHYTOSTEROL; SITOSTEROL;

ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; GERMANY; HUMAN; MICTURITION DISORDER; PROSTATE HYPERTROPHY; URINE FLOW RATE;

EID: 0142178206     PISSN: 0722348X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Berges RR, Kassen A, Senge T: Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up. BJU 2000; 85: 842-846.
2. Berges RR, Windeler J, Trampisch HJ, Senge T and the Beta-sitosterol Study Group: Randomized, placebo-controlled, double blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Lancet 1995; 345: 1529-1532.
3. Kassen, A, Berges RR, Senge T: Effect of beta-sitosterol on transforming growth factor-beta-1 expression and translocation protein kinase C alpha in human prostate stromal cells in vitro. Eur Urol 2000; 37: 735-741.
4. Zahradnik HP, Schillfahrt R, Schoening R, Ebbinghaus KD, Dunzendorfer U: Prostaglandingehalt in Prostata-Adenomen nach Behandlung mit einem Sterol. Fortschr Med. 1980; 98: 69-72.